Compare ARK Genomic Revolution ETF (ARKG) vs Rex Fang & Innovation Equity Premium Income ETF (FEPI) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Rex Fang & Innovation Equity Premium Income ETF — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Rex Fang & Innovation Equity Premium Income ETF trades at $42.57. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Rex Fang & Innovation Equity Premium Income ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | FEPI | |
|---|---|---|
Sector | Sector/Thematic | Income / Options Overlay |
52-Week High | $43.57 | $49.54 |
52-Week Low | $23.09 | $38.13 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
FEPI (REX FANG & Innovation Equity Premium Income ETF) trades at $42.68, up 0.19% on the day, with a bearish technical signal from moving averages. The ETF generates high income through weekly dividends, recently transitioning to weekly distributions to enhance cash flow. Its covered call strategy on concentrated tech and AI stocks provides a high yield but limits upside potential and exposes investors to net asset value erosion during market downturns.
The outlook for FEPI hinges on its ability to sustain high dividend yields amid volatile tech markets. Investment opportunities include consistent weekly income, but risks involve capped gains from call writing and sensitivity to tech sector swings. Analyst sentiment is mixed, balancing yield appeal with structural limitations that may hinder long-term growth compared to broad market ETFs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Rex Fang & Innovation Equity Premium Income ETF
FEPI provides exposure to top innovation stocks while generating monthly income. It uses a covered call strategy on high-volatility tech stocks to capture option premiums for investors.
Read more on FEPI →
